Swimming training for asthma in children and adolescents aged 18 years and under (Review)

Size: px
Start display at page:

Download "Swimming training for asthma in children and adolescents aged 18 years and under (Review)"

Transcription

1 Swimming training for asthma in children and adolescents aged 18 years and under (Review) Beggs S, Foong YC, Le HCT, Noor D, Wood-Baker R, Walters JAE This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2013, Issue 4

2 T A B L E O F C O N T E N T S HEADER ABSTRACT PLAIN LANGUAGE SUMMARY SUMMARY OF FINDINGS FOR THE MAIN COMPARISON BACKGROUND OBJECTIVES METHODS RESULTS Figure Figure Figure Figure Figure Figure DISCUSSION AUTHORS CONCLUSIONS ACKNOWLEDGEMENTS REFERENCES CHARACTERISTICS OF STUDIES DATA AND ANALYSES Analysis 1.1. Comparison 1 Swimming training versus control, Outcome 1 Quality of life Analysis 1.2. Comparison 1 Swimming training versus control, Outcome 2 Symptoms (change) Analysis 1.3. Comparison 1 Swimming training versus control, Outcome 3 Change in asthma symptoms (all) Analysis 1.4. Comparison 1 Swimming training versus control, Outcome 4 Urgent asthma physician visits Analysis 1.5. Comparison 1 Swimming training versus control, Outcome 5 Asthma consultation (1 or more) during intervention Analysis 1.6. Comparison 1 Swimming training versus control, Outcome 6 FEV1 L Analysis 1.7. Comparison 1 Swimming training versus control, Outcome 7 FEV1 % predicted (change) Analysis 1.8. Comparison 1 Swimming training versus control, Outcome 8 FVC L Analysis 1.9. Comparison 1 Swimming training versus control, Outcome 9 FVC % predicted (change) Analysis Comparison 1 Swimming training versus control, Outcome 10 FEF 25% to 75 % predicted (change). 49 Analysis Comparison 1 Swimming training versus control, Outcome 11 FEF 25% to 75% L Analysis Comparison 1 Swimming training versus control, Outcome 12 FEF 50 % predicted Analysis Comparison 1 Swimming training versus control, Outcome 13 PEF L/min Analysis Comparison 1 Swimming training versus control, Outcome 14 Exercise capacity: VO2 max (ml/kg/min). 52 Analysis Comparison 1 Swimming training versus control, Outcome 15 Exercise Capacity: other measures (control: usual care) Analysis Comparison 1 Swimming training versus control, Outcome 16 Exercise Capacity: Any measure (control: usual care) Analysis Comparison 1 Swimming training versus control, Outcome 17 Distance fitness tests-all (m) Analysis Comparison 1 Swimming training versus control, Outcome 18 Distance fitness tests-all (m) Analysis Comparison 1 Swimming training versus control, Outcome 19 Bronchial hyper-responsiveness: ln PC20 methacholine Analysis Comparison 1 Swimming training versus control, Outcome 20 Exercise induced bronchoconstriction (maximum fall in FEV1 (%) ADDITIONAL TABLES APPENDICES CONTRIBUTIONS OF AUTHORS DECLARATIONS OF INTEREST SOURCES OF SUPPORT DIFFERENCES BETWEEN PROTOCOL AND REVIEW i

3 [Intervention Review] Swimming training for asthma in children and adolescents aged 18 years and under Sean Beggs 1, Yi Chao Foong 2, Hong Cecilia T Le 2, Danial Noor 2, Richard Wood-Baker 3, Julia AE Walters 2 1 Department of Paediatrics, Royal Hobart Hospital, Hobart, Australia. 2 School of Medicine, University of Tasmania, Hobart, Australia. 3 Tasmanian School of Medicine, University of Tasmania, Hobart, Australia Contact address: Julia AE Walters, School of Medicine, University of Tasmania, Hobart, Tasmania, 7000, Australia. Julia.Walters@utas.edu.au. Editorial group: Cochrane Airways Group. Publication status and date: New, published in Issue 4, Review content assessed as up-to-date: 12 July Citation: Beggs S, Foong YC, Le HCT, Noor D, Wood-Baker R, Walters JAE. Swimming training for asthma in children and adolescents aged 18 years and under. Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD DOI: / CD pub2. Background A B S T R A C T Asthma is the most common chronic medical condition in children and a common reason for hospitalisation. Observational studies have suggested that swimming, in particular, is an ideal form of physical activity to improve fitness and decrease the burden of disease in asthma. Objectives To determine the effectiveness and safety of swimming training as an intervention for asthma in children and adolescents aged 18 years and under. Search methods We searched the Cochrane Airways Group s Specialised Register of trials (CENTRAL), MEDLINE, EMBASE, CINAHL, in November 2011, and repeated the search of CENTRAL in July We also handsearched ongoing Clinical Trials Registers. Selection criteria We included all randomised controlled trials (RCTs) and quasi-rcts of children and adolescents comparing swimming training with usual care, a non-physical activity, or physical activity other than swimming. Data collection and analysis We used standard methods specified in the Cochrane Handbook for Systematic reviews of Interventions. Two review authors used a standard template to independently assess trials for inclusion and extract data on study characteristics, risk of bias elements and outcomes. We contacted trial authors to request data if not published fully. When required, we calculated correlation coefficients from studies with full outcome data to impute standard deviation of changes from baseline. 1

4 Main results Eight studies involving 262 participants were included in the review. Participants had stable asthma, with severity ranging from mild to severe. All studies were randomised trials, three studies had high withdrawal rates. Participants were between five to 18 years of age, and in seven studies swimming training varied from 30 to 90 minutes, two to three times a week, over six to 12 weeks. The programme in one study gave 30 minutes training six times per week. The comparison was usual care in seven studies and golf in one study. Chlorination status of swimming pool was unknown for four studies. Two studies used non-chlorinated pools, one study used an indoor chlorinated pool and one study used a chlorinated but well-ventilated pool. No statistically significant effects were seen in studies comparing swimming training with usual care or another physical activity for the primary outcomes; quality of life, asthma control, asthma exacerbations or use of corticosteroids for asthma. Swimming training had a clinically meaningful effect on exercise capacity compared with usual care, measured as maximal oxygen consumption during a maximum effort exercise test (VO2 max) (two studies, n = 32), with a mean increase of 9.67 ml/kg/min; 95% confidence interval (CI) 5.84 to A difference of equivalent magnitude was found when other measures of exercise capacity were also pooled (four studies, n = 74), giving a standardised mean difference (SMD) 1.34; 95% CI 0.82 to Swimming training was associated with small increases in resting lung function parameters of varying statistical significance; mean difference (MD) for FEV1 % predicted 8.07; 95% CI 3.59 to In sensitivity analyses, by risk of attrition bias or use of imputed standard deviations, there were no important changes on effect sizes. Unknown chlorination status of pools limited subgroup analyses. Based on limited data, there were no adverse effects on asthma control or occurrence of exacerbations. Authors conclusions This review indicates that swimming training is well-tolerated in children and adolescents with stable asthma, and increases lung function (moderate strength evidence) and cardio-pulmonary fitness (high strength evidence). There was no evidence that swimming training caused adverse effects on asthma control in young people 18 years and under with stable asthma of any severity. However whether swimming is better than other forms of physical activity cannot be determined from this review. Further adequately powered trials with longer follow-up periods are needed to better assess the long-term benefits of swimming. P L A I N L A N G U A G E S U M M A R Y Swimming training for asthma in children and adolescents aged 18 years and under Asthma is a common condition among children and adolescents causing intermittent wheezing, coughing and chest tightness. Concerns that physical exercise, such as swimming, can worsen asthma may reduce participation, and result in reduced physical fitness. This review aimed to determine the effectiveness and safety of swimming training in children and adolescents with asthma who are aged 18 years and under. We reviewed a total of eight studies involving 262 participants between the ages of five and 18 years with well-controlled asthma. They underwent swimming training varying from 30 to 90 minutes two to three times a week over six to 12 weeks in seven studies, and in one study training lasted 30 minutes six times per week. This review found that for swimming training compared to control (either usual care or another physical activity), there were improvements in resting lung function tests, but no effects were found on quality of life, control of asthma symptoms or asthma exacerbations. Physical fitness increased with swimming training compared with usual care. There were few reported adverse asthmatic events in swimming training participants during the programmes. The relatively small number of studies and participants limits this review s ability to measure some outcomes that are of interest, particularly the impact on quality of life and asthma exacerbations. In summary, swimming training is well-tolerated in children and adolescents with stable asthma, and increases physical fitness and lung function. However, whether swimming is better and/or safer than other forms of physical activity cannot be determined from this review. Further studies with longer follow-up periods may help us understand any long-term benefits of swimming. 2

5 S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation] Swimming training for asthma in children and adolescents aged 18 years and under Patient or population: children and adolescents aged 18 years and under studies with asthma Settings: Recruited from asthma clinics. Asthma diagnosis by recognised criteria. Intervention: Swimming training programme- meeting minimum intensity criteria(> Weekly, > 20 minutes, > 4 weeks) Outcomes Illustrative comparative risks*(95% CI) Relative effect (95% CI) No of Participants (studies) Quality of the evidence (GRADE) Comments Assumed risk Corresponding risk Control Swimming training Qualityoflife 1 Paediatric Asthma Quality of Life Questionnaire (PAQLQ). Scale from: 1 (worse) to 7(better). Follow-up: mean 9 weeks Themeanchangeinquality of life in the control group was-1.87 Themeanchangeinquality of life in the intervention group was 0.26(1.05lowerto1.58 higher) 50 (1study 1 ) low 2,3 Asthma symptoms Different scales in different studies(lower scores mean fewer symptoms) Follow-up: 6-9 weeks The mean change in asthma symptoms ranged across control groups from 0 to standard deviations The mean asthma symptoms in the intervention groups was 0.06 standard deviations less (0.58 lower to 0.47 higher) see comment 58 (2 studies) The difference of 0. low 3,4,5 06 standard deviations would equate to a small difference on Living with Asthma Questionnaire (LWAQ) or a composite 12-point scale of <0.5 units. The effect size is <0.2 representing a small effect Exacerbations requiring hospital admission see comment see comment see comment see comment - Outcome not reported 3

6 Exacerbations requiring a course of oral corticosteroids Urgent asthma physicianvisits 1 Number of times the child visited a physician s office/clinic for an asthma flare up Follow-up: mean 2 months Resting lung function Forced expiratory volume (FEV1) in 1 second (litres) Follow-up: 6-12 weeks Fitness 6 Maximal oxygen consumption(vo2 max) Follow-up: mean 12 weeks see comment see comment see comment see comment - Outcome not reported The mean urgent asthma physician visits in the control group was 0.17visitsin2months The mean urgent asthma physician visits in the intervention groups was 0.08 higher (0.25 lower to 0.42 higher) 44 (1study 1 ) moderate 3 Themeanchangeinresting FEV1 ranged across control groups from litres The mean difference in FEV1 in the intervention groups was 0.10 L higher (0to0.2higher) 113 (4 studies) The mean difference is moderate 3 comparable to the difference in FEV1 in children with asthma (N = 4,n=719 7 )comparing low dose fluticasone propionate (100 mcg) daily with placebo mean difference(md)0.1l[0.15,0. 36](Adams 2008) The mean VO2 max in usual care control groups was 39 ml/kg/min The mean fitness in the swimming intervention groups was 9.67 ml/kg/min higher (5.84 to higher) 32 (2 studies) high The 25% difference for swimming compared to control in VO2 max is clinically meaningful. It is larger than the differences seen in physical activity studies in children without asthma, range 5% to 15% (Armstrong 2011) and that seen in children with asthma undertaking physical training 9%(Counil2003). 4

7 *Thebasisfortheassumedriskisprovidedinthetable.Thecorresponding risk(andits95%confidenceinterval)isbasedontheassumedriskinthecomparisongroupandtherelative effect of the intervention(and its 95% CI). CI: Confidence interval; FEV1 forced expiratory volume in one second; L: litres; GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Lowquality:Furtherresearchisverylikelytohaveanimportantimpactonourconfidenceintheestimateofeffectandislikelytochangetheestimate. Very low quality: We are very uncertain about the estimate. 1 Controlgroup:golf 2 Highriskofattritionbiasassessedinstudy 3 Theconfidenceintervaldoesnotruleoutanulleffectorharm 4 Comparisongroupsdiffered;usualcareorgolf 5 Effectsize<0.2representssmalleffect 6 Pooledstudieswithnon-activeusualcarecontrolgrouponly 7 N=numberofstudies;n=numberofparticipant 5

8 B A C K G R O U N D Description of the condition Originating from the Greek word panting, asthma is a disease associated with chronic inflammation of the airways accompanied by hyper-reactive responses of the bronchi (Ward 2002). These heightened responses result in the obstruction of airflow, which manifests as symptoms such as coughing, wheezing, chest tightness and shortness of breath (Beilby 2006). Asthma is the most common chronic medical condition among children and is one of the most common causes of hospitalisation and medical visits in the same age group (World Health Organization Media Centre 2011). It is estimated that 235 million people have asthma, while approximately a quarter of the 40 million Americans with asthma are children under the age of 17 (American Lung Association 2010). Multiple epidemiological studies from around the world indicate that the prevalence of asthma among children and adolescents is rising (Wong 2008). Physical activity can lead to increased airway resistance in many people with asthma, precipitating an episode of exercise-induced asthma. Fear of such episodes may lead to decreased participation in physical activity, as suggested by numerous studies that have reported that children with asthma have lower cardiorespiratory fitness than their peers (Clark 1988; Lang 2004; Welsh 2005). Description of the intervention Several studies in children with asthma have demonstrated that physical exercise does improve aerobic fitness as well as reduce episodes of wheeze, hospitalisations, school absenteeism and, to a lesser degree, medication usage (Welsh 2005). As a subtype of physical training, swimming is often suggested as the ideal form of physical activity for individuals with asthma. Swimming training is a structured regular exercise programme through supervised aquatic activities, which aims to increase cardiorespiratory fitness. How the intervention might work There are a number of postulated reasons as to why swimming training may be superior to other forms of physical training for children with asthma. These include, the air above the pool being warmer and humidified, low pollen count exposure, hydrostatic pressure on the chest wall reducing expiratory effort and work, relative hypoventilation due to controlled breathing leading to increased carbon dioxide and horizontal posture (Bar-Or 1992; Bernard 2010; Downing 2011; Inbar 1991; Wardell 2000). These are on top of the effects of any physical training, namely increased self-esteem, self-confidence and improved cardio-pulmonary fitness. Of note however, are the concerns raised over the past decade in relation to the potential pro-asthmatic effect of chlorine byproducts in pools (Nickmilder 2007; Uyan 2009). Why it is important to do this review Asthma is an increasingly common chronic disease in many parts of the world and it has become important to identify safe and potentially beneficial exercises for the condition. Swimming is a form of exercise that has been commonly lauded as healthy for people with asthma, often being implemented in guidelines without an explicit evidence base. Several reviews have been done and many emphasise the need for further research and analysis of the existing literature on the subject (Chandratilleke 2012; Fisk 2010; Goodman 2008; Ram 2000; Ram 2005). There has been no shortage of studies on the effect of swimming, often with different results and study designs. Thus it is crucial to provide a systematic analysis and critical appraisal of the current research finding and identify whether swimming is safe and beneficial for children and adolescents with asthma. It is also important to establish the safety of swimming training for people with asthma, especially in light of the concerns about chlorinated pools (Bernard 2003; Bernard 2006a). O B J E C T I V E S To determine the effectiveness and safety of swimming training as an intervention for asthma in children and adolescents aged 18 years and under. M E T H O D S Criteria for considering studies for this review Types of studies We included all available randomised controlled trials (RCTs) and quasi-rcts (i.e. using a quasi-random allocation method such as allocation by date of birth or day of the week) of children undergoing swimming training. We identified and included studies reported in abstract form and requested data from trialists where no full publication was found. We did not impose any restrictions on language, year of publication and type of publication of a study. Types of participants We included studies of children and adolescents aged 18 years and under, with physician-diagnosed asthma or based on objective criteria as stated in study methods, such as bronchodilator response, or both. We included studies with participants having any severity of asthma. 6

9 Types of interventions We included studies with swimming training, defined as a formal swimming programme of at least one session per week, with each session lasting at least 20 minutes and running over a minimum of four weeks. Studies could have a comparison group receiving usual care without any intervention, or undertake a non-physical activity or physical activity other than swimming. Types of outcome measures We assessed the effects of interventions in these categories of outcomes where available: patient-related, health economic and objective measures of lung function, airway reactivity and inflammation and exercise*). We conducted additional searches of CENTRAL, PubMed, CINAHL and EMBASE. See Appendix 2 for the search strategies. Searches were conducted in November A repeat search of Cochrane Central Register of Controlled Trials (CEN- TRAL) database in July 2012 did not find any new studies. We conducted a search of national and international trial registers including The Australian New Zealand Clinical Trials Registry, Chinese Clinical Trial Register, ClinicalTrials.gov register, Current Controlled Trials metaregister of Controlled Trials (mrct) - active registers, Hong Kong clinical trials register, International Clinical Trials Registry Platform Search Portal, South African National Clinical Trial Register and UK Clinical Trials Gateway. We searched all databases from their inception to the present, with no restriction on language of publication. Primary outcomes 1. Quality of life measured by disease specific or generic questionnaires (e.g. Paediatric Asthma Quality of Life Questionnaire (PAQLQ) (Juniper 1996). 2. Asthma control measured by questionnaires/symptom diaries. 3. Exacerbations of asthma requiring attendance at hospital. 4. Systemic steroid use for exacerbations of asthma. Secondary outcomes 1. Bronchodilator use. 2. Use of preventer medication (e.g. inhaled corticosteroids [ICS]). 3. Lung function (including peak expiratory flow (PEF), forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC)). 4. Exercise capacity (cardio-pulmonary fitness). 5. Bronchial hyper-responsiveness (determined by a formal direct or indirect challenge test). 6. Time-off required from employment or education. 7. Utilisation of healthcare services. Search methods for identification of studies Electronic searches We identified trials using the Cochrane Airways Group s Specialised Register of trials, which is derived from systematic searches of bibliographic databases including the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, latest issue), MEDLINE, EMBASE, CINAHL, AMED and Psych- INFO and handsearched respiratory journals and meeting abstracts (please see Appendix 1 for further details). The TSC searched all records in the Specialised Register coded as asthma using the following terms: swim* or pool* or ((water* or aquatic*) Searching other resources We checked reference lists of all studies assessed to identify other relevant studies. We consulted experts in the field for ongoing or unpublished studies. We contacted the author(s) of any identified abstracts or unpublished studies to ascertain the study design and outcome measures. We included abstracts and unpublished studies if sufficient information on the study design was available, but only included them in the meta-analysis where we had data on outcome measures. Data collection and analysis Selection of studies At least two review authors (YF, HL, WN) independently identified studies and assessed whether they met the inclusion criteria. We resolved any discrepancies through consultation with a third review author (JW, RWB, or SB). The review authors initially identified studies for inclusion based on citation and abstract but if there was insufficient information to make a determination, we retrieved the full article. We eliminated duplicate studies by comparing authors names and titles of studies. Data extraction and management At least two review authors (JW, WN, HL, YF) independently extracted and entered data onto a standard extraction form. We extracted the following characteristics. Methods: study design, location, number of centres, duration of study; methods of analysis. Participants: recruitment, target participants, N screened, N randomised, N completed, asthma diagnosis criteria, severity of asthma, gender, age, other inclusion criteria, exclusion criteria. Interventions: setting of intervention: indoor/outdoor, chlorinated/non-chlorinated; swimming training supervisor; 7

10 description of intervention: length session/frequency, duration; control; co-interventions. Outcomes: pre-specified, follow-up period. Coding for subgroup analysis: adolescents/children; asthma mild/ moderate/severe, length swimming session, indoor/outdoor pool, chlorinated/non-chlorinated. Any discrepancies were resolved though consultation with a third review author. Assessment of risk of bias in included studies Two review authors (YF, HL, WN) independently assessed risk of bias for each study using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). Since it was not possible to blind participants in these studies this criterion was not assessed. Disagreement was resolved by discussion or by involving a third review author (JW). We examined Risk of bias assessment through the synthesis of a Risk of bias table. We assessed the risk of bias according to the following domains. 1. Random sequence generation. 2. Concealment of allocation. 3. Blinding of assessors. 4. Incomplete outcome data. 5. Selective outcome reporting. We noted any other potential sources of bias. We graded each domain as having low, high or unclear risk of bias. measurements had no effect on the eventual outcome data for that study. We addressed missing standard deviations by imputing data, either using studies in the same meta-analysis or for changes from baseline (Abrams 2005), calculating a correlation coefficient from baseline and final measurements for outcomes available in other studies (see Table 1). We used the correlation coefficients to calculate and impute the standard deviation of change from baseline. We explored the impact of imputation in the overall assessment of results by sensitivity analyses. Assessment of heterogeneity We used the I 2 statistic to measure heterogeneity among the trials in each analysis Higgins Interpretation of statistical heterogeneity was according to the recommendation of Higgins 2011, as follows: 0% to 40%: might not be important; 30% to 50%: may represent moderate heterogeneity; 50% to 90%: may represent substantial heterogeneity; Where substantial heterogeneity ( I 2 > 50%) was identified, we explored it using pre-specified subgroup analyses where possible. Assessment of reporting biases Where reporting bias was indicated (see Selective reporting bias above), we attempted to contact study authors to ask them to provide missing outcome data. Measures of treatment effect If studies used the same scale to measure a continuous outcome, for example lung function or asthma medication use, we calculated mean differences (MDs) and 95% confidence intervals (CIs) using change from baseline where data were available. However, if the measurements pre- and post intervention were unavailable we used the absolute values in the groups. Where different scales were used to measure a continuous outcome, we calculated a standardised mean difference (SMD) and 95% CI. We determined the minimum threshold for a clinically significant effect for outcomes such as asthma control, via established published standards. For dichotomous outcomes (exacerbations of asthma or adverse events), we expressed results as Peto odds ratio (Peto OR) with 95% CI. Dealing with missing data We assessed categories of missing data under missing outcomes, missing summary data and missing individuals as in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). We noted missing or unclear data on data collection forms and contacted trial authors for clarification. We also asked study authors to provide data for unreported outcomes. We assumed that loss of participants occurring prior to performance of baseline Data synthesis We combined studies that measured the same outcome in metaanalyses where data were available. Where there was a high level of heterogeneity we considered three options; not conducting a meta-analysis, exploring causes of heterogeneity and conducting a random-effects meta-analysis. Subgroup analysis and investigation of heterogeneity We pre-specified subgroup analyses between the following groups where sufficient studies could be included. 1. Purely observed versus non-physical versus physical (nonswimming) controls. 2. People under 12 years of age, and those 12 years and above. 3. Severity of asthma as defined in the included studies. 4. Length of swimming session. 5. Chlorinated versus non-chlorinated indoor pools. 6. Indoor versus outdoor pools. Sensitivity analysis We identified studies with a high risk bias random sequence generation, concealment of allocation, incomplete outcome data or selective outcome reporting and conducted sensitivity analyses (by 8

11 excluding these studies). We did not consider blinding as this was not possible due to the nature of the intervention. Pooled results obtained using absolute outcome values were compared with pooled results using change values in sensitivity analyses presented in Table 2 and Table 3. Pooled results using standard deviations for change values were compared when calculated from coefficients from different studies in sensitivity analyses presented in Table 2 and Table 3. R E S U L T S Description of studies See: Characteristics of included studies; Characteristics of excluded studies. Results of the search See Figure 1 Figure 1. PRISMA flow diagram 9

12 There were 1520 citations identified from the initial search of the pre-specified databases but no relevant studies from trial registers. Three additional articles were retrieved following handsearching of reference lists of potentially relevant studies and another two were added from studies included in a Cochrane Systematic Review entitled Physical training for asthma (Chandratilleke 2012). There were a total of 1367 citations after duplicates were removed, of which 1242 were removed after title screening by two review authors. The remaining 125 articles were screened by two review authors based on their abstracts. From this, 40 were identified as potentially relevant and full text articles were retrieved. Additional data on eligibility were requested from trial authors if required, following which at least two review authors independently agreed that eight articles fulfilled the study inclusion criteria of the review (Altintas 2003; Matsumoto 1999; Varray 1991; Varray 1995; Wang 2009; Weisgerber 2003; Weisgerber 2008; Wicher 2010). The remaining 32 citations were excluded and reasons for exclusion have been specified. See Characteristics of excluded studies. Included studies See Characteristics of included studies and Table 4 and Table 5. Eight studies involving 262 children or adolescents, published between 1991 and 2010, met the inclusion criteria. Sample sizes ranged from 14 to 71 participants. All studies were randomised controlled trials of children or adolescents with asthma, with swimming training in the intervention group. Swimming training programmes varied; in seven studies swimming sessions lasted for between 30 and 90 minutes, occurring two to three times a week with the length of the swimming training programme varying from six to 12 weeks. In Matsumoto 1999 the sessions were 30 minutes long but occurred six times a week for participants with severe asthma who had been recruited after an inpatient exacerbation. Seven pools were located indoors; one pool was chlorinated (Weisgerber 2008), one pool was chlorinated and well-ventilated (Wicher 2010) and one pool was non-chlorinated (Altintas 2003). In four studies chlorination status was not unspecified (Matsumoto 1999; Varray 1991; Varray 1995; Weisgerber 2003). The pool was outdoor and non-chlorinated in Wang The comparison group was usual care without any intervention in seven studies. One study compared golf sessions for the equivalent time to the swimming group (Weisgerber 2008). The lowest age of participants was five years (Altintas 2003). Two studies recruited children from seven or eight to 12 years (Matsumoto 1999; Wang 2009), while the upper age of participants was 13 or 14 years in five studies (Altintas 2003; Varray 1991; Varray 1995; Weisgerber 2003; Weisgerber 2008) and 18 years in one trial (Wicher 2010). The proportion of male participants varied between 44% to 88%. Asthma diagnosis was based on guidelines specified criteria in six studies (Altintas 2003; Matsumoto 1999; Wang 2009; Weisgerber 2003; Weisgerber 2008; Wicher 2010) and in these studies asthma was specified as persistent with severity graded as severe in Matsumoto 1999, moderate in Wicher 2010 and either mild/ moderate/severe in Wang 2009; Weisgerber 2003; Weisgerber Diagnosis of asthma was based on clinical criteria with atopy and bronchodilator responsiveness in two studies (Varray 1991; Varray 1995) which did not specify asthma severity. Participants regular medication for asthma was continued during the study in six studies but three did not specify medications used (Varray 1995; Wang 2009; Weisgerber 2003). Participants used inhaled corticosteroids in Matsumoto 1999 (52%), Weisgerber 2008 (50%). All participants in Altintas 2003 were treated with inhaled corticosteroids ( mcg beclomethasone equivalent/ day) and in Wicher 2010, all participants were treated with both inhaled corticosteroids (1000 mcg beclomethasone equivalent/ day) and long-acting beta-agonists (formoterol 12 mcg two times a day). Excluded studies Thirty-two studies were excluded with reasons provided in Characteristics of excluded studies table. Two studies reported insufficient details about the methods of randomisation, or reported an inadequate method of allocation (Fitch 1976; Huang 1989). Risk of bias in included studies Assessment of study quality was limited by incomplete data (Figure 2). 10

13 Figure 2. Risk of bias summary: review authors judgements about each risk of bias item for each included study. 11

14 Allocation All eight included studies were randomly allocated but of these only four had detailed descriptions regarding the method of randomisation and were judged to be at low risk of bias (Altintas 2003; Varray 1995; Weisgerber 2003; Weisgerber 2008). Only Weisgerber 2008 and Altintas 2003 supplied details regarding allocation concealment, and the other six studies were classified as unclear risk of bias for allocation. Blinding Due to the nature of the study interventions blinding of participants was not possible. All studies were classified as being of high risk for performance bias. No studies specified blinding of outcome assessors although in Matsumoto 1999 it is likely they were aware of group allocation. Incomplete outcome data Three studies with a high withdrawal rate were judged to be at high risk of bias (Weisgerber 2003; Weisgerber 2008;Wicher 2010). The remaining four studies were judged to be at low risk of bias. Selective reporting Although study protocols were not available, three studies were judged at low risk of bias. Authors of three studies responded to requests for study outcome data; Altintas 2003 supplied group results, and individual patient data were supplied for Weisgerber 2003 and Weisgerber Five studies were judged at unclear risk of bias. Other potential sources of bias No other source of bias were identified. Effects of interventions See: Summary of findings for the main comparison Swimming training for asthma in children and adolescents aged 18 years and under Primary outcomes Quality of life Only one study involving 50 participants (Weisgerber 2008) used a validated assessment tool to measure quality of life. This study reported the Pediatric Asthma Quality of Life Questionnaire (PAQLQ) (Juniper 1996); total (23 items, 1 = maximal impairment, 7 = no impairment) measuring overall functional problems for an individual with asthma (physical symptoms, emotional and social). Changes in parental quality of life were measured using the Pediatric Asthma Caregiver s Quality of Life Questionnaire (Juniper 1996a) (PACQLQ) measuring the problems that are most troublesome to the parents (primary caregivers) of children with asthma (13 items in two domains, activity limitation and emotional function and overall score, seven-point scale, 1 = maximal impairment, 7 = no impairment). In Weisgerber 2008, no significant differences were found between swimming and golf groups in quality of life for children PAQLQ total (mean difference (MD) 0.26; 95% confidence interval (CI) to 1.58), or in the PAQLQ symptom domain (MD 0.07; 95% CI to 1.26), or for caregivers quality of life, PACQLQ total MD 0.71; 95% CI to 2.25 (Analysis 1.1). Asthma control Four studies (Varray 1991; Weisgerber 2003; Weisgerber 2008; Wang 2009) measured the impact of swimming on asthma symptoms. Only one study (Weisgerber 2008) used a validated assessment tool. This study reported the Living with Asthma Questionnaire Index (LWAQ index, Hyland 1991) (three items for parental report of asthma symptoms; high score indicating worse effects). In a comparison of swimming and golf exercise groups for this study (n = 50), no significant difference was found for symptoms (MD LWAQ index: 95% CI to 2.36) (Analysis 1.2). Weisgerber 2003 (n = 8) used a non validated questionnaire (score 4 better-16 worse) that assessed nocturnal coughing, daytime asthma symptoms, effect on activity and use of rescue inhaler. There was no significant difference in scores between swimming and control groups, (MD -0.80; 95% CI to 3.04) (Analysis 1.2). In Wang 2009, asthma severity was assessed using the National Heart, Lung, and Blood Institute (NHLBI) criteria (symptoms: nocturnal awakening, rescue use, activity limitation). They reported a significant improvement in asthma severity post-intervention in the swimming group compared with the control group but did not show data. Varray 1991 noted symptom status in a qualitative manner with parents reporting participants in the swimming group did not have any decrease in frequency of wheezing attacks or use of regular asthma medication. We combined the results in a meta-analysis from Weisgerber 2003 and Weisgerber 2008 (n = 58), in which symptoms were measured on differing scales, and found no statistically significant difference between swimming and control groups, (standardised mean difference (SMD) -0.06; 95% CI to 0.47) (Analysis 1.3; Figure 12

15 3). Figure 3. Forest plot of comparison: 1 Swimming training versus control, outcome: 1.3 Change in asthma symptoms (all). Exacerbations No data were available for meta-analysis of number of exacerbations or exacerbation frequency. Weisgerber 2008 reported that five symptom exacerbations occurred during 700 person-sessions of the swimming programme (7.1 per 1000 sessions) and one symptom exacerbation occurred during 425 person-sessions of golf (2.4 per 1000 sessions). All episodes resolved with the use of bronchodilator and none required a clinic visit, emergency department (ED) visit, or hospitalisation. Wicher 2010 reported that no participant was admitted to hospital for asthma attacks during in the run in or during the training period in either the swimming or control group. Corticosteroid use for exacerbations of asthma None of the eight included studies reported data on oral steroid use during the study period. Secondary outcomes No studies reported results for bronchodilator use or time off education/work. Preventer medication use In Wicher 2010 all participants used fluticasone 500 mcg daily and authors reported that adherence to treatment with fluticasone and use of rescue salbutamol was similar in the swimming and control groups. Utilisation of healthcare Weisgerber 2008 assessed the number of times the child visited the physician s office/clinic or the ED for an asthma flare up in two months preceding the exercise intervention and during the twomonth intervention period. Prior to the study, 41% had an urgent asthma physician visit (n = 44) and 18% an urgent asthma ED visit. There was a statistically significant decrease in urgent asthma physician visits in the pooled single exercise cohort analysis. Participants averaged fewer urgent visits to the clinic for asthma exacerbations during the two months they participated in the intervention compared with the prior two months, mean -1.1; SD 3.3 (P = 0.04). In separate group analyses, the decrease in urgent asthma physician visits in the swimming group (n = 27) using the Wilcoxon signed-rank test was statistically significant (P = 0.03) but not in the golf group (n = 17). However, a comparison of the swimming training and golf groups for urgent asthma physician visits over the two-month study intervention (Analysis 1.4) did not show a significant difference (MD 0.08; 95% CI to 0.42), and the likelihood of at least one urgent asthma physician visit was not significantly increased, (Peto odds ratio (OR) 1.64; 95% CI 0.32 to 8.44) (Analysis 1.5). No urgent asthma ED visits occurred in the golf group during the intervention, but the likelihood was not significantly different between swimming training and golf groups (Peto OR 5.77; 95% CI 0.72 to 46.46) (Analysis 1.5). 13

16 Lung function Lung function was assessed at baseline and on completion of the intervention or control period. FEV1: Four studies (n = 113) contributed data on FEV1 (Varray 1991; Wang 2009; Weisgerber 2003; Wicher 2010). The change in FEV1 for swimming training compared with control was small and of borderline statistical significance (MD 0.10 L; 95% CI to 0.20), with low heterogeneity I² = 32% (Analysis 1.6). Results for FEV1 % predicted in Wicher 2010 were not included in the meta-analyses as they did not appear compatible with FEV1 results. We requested that the trial authors check their accuracy but no response was received so data were not incorporated into the meta-analysis. In four studies (Altintas 2003; Wang 2009; Weisgerber 2003; Weisgerber 2008), FEV1 % predicted (n = 83) was significantly greater in the swimming group (MD 8.07; 95% CI 3.59 to 12.54), with moderate heterogeneity I² = 38% (Analysis 1.7; Figure 4). Figure 4. Forest plot of comparison: 1 Swimming training versus control, outcome: 1.7 FEV1 % predicted (change). FVC: Four studies (n = 113) contributed data on FVC (Varray 1991; Wang 2009; Weisgerber 2003; Wicher 2010). In a randomeffects meta-analysis, there was a small, statistically non-significant difference in FVC for swimming training compared with control (MD 0.10 L; 95% CI to 0.26), with substantial heterogeneity (I² = 57%) (Analysis 1.8). The difference in FVC % predicted in five studies (Altintas 2003; Wang 2009; Weisgerber 2003; Weisgerber 2008; Wicher 2010, n = 144) was not statistically significant (MD 3.85%; 95% CI to 8.28), with substantial heterogeneity present (I² = 61%) (Analysis 1.9). FEF 25-75: Four studies reported FEF 25% to 75% as per cent predicted (Wang 2009; Weisgerber 2003; Weisgerber 2008; Wicher 2010) but only Weisgerber 2003 reported absolute values. Random-effects pooled results indicated that swimming training had a significant effect on FEF25% to 75% predicted (MD 12.63; 95% CI 2.73 to 22.53; n = 118) with substantial heterogeneity, (I² = 59%) (Analysis 1.10). The difference between groups when measured in volume was not statistically significant, (MD 0.28 L; 95% CI-0.15 to 0.72; one study, n = 8) (Analysis 1.11). PEF (L/min): Peak flow was assessed in Wang 2009 and Weisgerber 2003 (n = 38) and the pooled result demonstrated substantial heterogeneity (I² = 59%). The random-effects meta-analysis favoured the swimming group compared with control (MD L/min; 95% CI to ) (Analysis 1.13). Exercise capacity and fitness Five studies assessed the effects of swimming on exercise capacity and fitness (Altintas 2003; Matsumoto 1999; Varray 1991; Varray 1995; Weisgerber 2008), but they used a variety of different measures. The accepted gold standard for fitness testing is maximal oxygen consumption in ml/kg/min (VO 2 max) during a maximal effort test in the exercise laboratory. Index Physical Work Capacity (PWC)170 is the work load performed on any type of ergometer resulting in a heart rate of 170/min and is highly correlated to VO 2 max. Other distance-based tests have been developed to meet the need for simpler, inexpensive ways to assess aerobic fitness in children, such as the 20-metre shuttle run, the five-minute run, the six-minute run, the 15-minute run, the one-mile run, and Cooper 12-minute walk/run test (CT12). 14

17 VO 2 max (ml/kg/min) Varray 1991 and Varray 1995 conducted measurements in children (n = 32). Swimming training compared with usual care had a positive and significant effect on VO 2 max (MD 9.67 ml/kg/ min; 95% CI 5.84 to 13.51), with no heterogeneity (I 2 = 0%) (Analysis 1.14). Weisgerber 2008 compared swimming training and golf and undertook fitness testing for a subset of 19 of 45 participating children and adolescents, with no significant difference (MD ml/kg/min; 95% CI to 0.57) (Analysis 1.14). Studies with usual care or golf control groups were not pooled in view of the high heterogeneity, Chi² = 14.82, df = 2 (P = ); I² = 93% (Figure 5). Figure 5. Forest plot of comparison: 1 Swimming training versus control, outcome: 1.14 Exercise capacity: VO2 max (ml/kg/min). Other measures of exercise capacity Altintas 2003 measured Index PWC170 - the work load in watts performed on an ergometer (treadmill, cyclo ergometer) that will result with a heart rate of 170/min. The swimming group had a significantly greater PWC170 compared with the control group (MD 0.44 watts; 95% CI 0.13 to 0.75) (Analysis 1.15). Matsumoto 1999 (n = 16) measured aerobic capacity, defined as the work load at lactate threshold and found aerobic capacity significantly increased in all participants in the swimming training group. The difference for the swimming group compared with control for swimming ergometry was MD 0.22 kp; 95% CI 0.10 to 0.34 and for cycle ergometry (MD 6.80 kp; 95% CI 2.03 to 11.57) (Analysis 1.15). Results from four studies with a usual care control group (n = 74) that measured exercise capacity were pooled; Altintas 2003 (PWC170, Matsumoto 1999 (cycle ergometry), Varray 1991 and Varray 1995 (VO 2 max) (Analysis 1.16; Figure 6). A difference of equivalent magnitude to the pooled VO 2 max result was found, with a SMD (SMD) 1.34 ; 95% CI 0.82 to 1.86, and no heterogeneity (I² = 0%). 15

18 Figure 6. Forest plot of comparison: 1 Swimming training versus control, outcome: 1.16 Exercise Capacity: Any measure (control: usual care). Field fitness tests Altintas 2003 (n = 26) found no significant difference between swimming training and usual care control groups in the six-minute walk test (MD metres; 95% CI to 86.35) (Analysis 1.17). Weisgerber 2008 found no significant difference in the Coopers 12-minute walk-run test between swimming training and golf groups (MD ; 95% CI to ) (Analysis 1.17). Pooling both studies using a SMD did not show any significant difference between swimming training compared with control, SMD 0.15; 95% CI to 0.63, with moderate heterogeneity, I² = 52% (Analysis 1.18). Adverse effects Bronchial hyper-responsiveness Two individual studies (Matsumoto 1999; Wicher 2010) reported results for formal direct challenge tests but results in publications were incomplete and they could not be included in a meta-analysis. Matsumoto 1999 reported that the difference between the mean change in provocative concentration of histamine (PC20) causing a 20% fall in FEV1 in the training and control groups was not statistically significant (P = 0.16). Wicher 2010 (n = 61) measured the provocative concentration of methacholine PC20 causing a 20% fall in FEV1. Results for the groups separately were reported as showing a significant change in the swimming group pre- posttraining, PC mg/ml (SD 0.25) before to 0.63 mg/ml (SD 0.78), P = At the end of the study there was no significant difference between swimming and control groups (MD 0.41 Ln PC20; 95% CI to1.51) (Analysis 1.19). Exercise induced bronchoconstriction Matsumoto 1999 assessed exercise induced bronchoconstriction using swimming and cycle ergometry. The mean maximal percentage fall in FEV1 induced with the swimming and cycle ergometers work load set to 175% LT on the relative load was measured. Although a smaller decrease in FEV1 was seen in the swimming training group, the difference between swimming and control groups was not statistically significant (MD %; 95% CI to 6.83) for swimming ergometry and (MD -4.99%; 95% CI to 11.63) for cycle ergometry (Analysis 1.20). Subgroup analysis Pre-specified subgroup analyses on children versus adolescents or observed/non-physical/physical activity control groups were not conducted due to limited number of studies. Analyses of lung function measures comparing non-chlorinated pools and ventilated chlorinated pools with chlorinated indoor pools was limited due to the small number of studies and missing outcome data (Table 3). 16

19 Sensitivity analysis Change from baseline values were used in the outcomes, Pediatric Asthma Quality of Life Questionnaire (PAQLQ), Pediatric Asthma Caregiver s Quality of Life Questionnaire (PACQLQ) and Living with Asthma Questionnaire Index (LWAQ index), FEV1, FVC FEF 25% to 75%. Analyses using absolute values are shown for comparison in Table 2 and Table 3. Results did not differ by direction nor greatly in magnitude. Correlation coefficients between baseline and final measurements were calculated from two studies (Weisgerber 2003 and Weisgerber 2008) and are shown for comparison in Table 1. We used the correlation coefficients from both to calculate and impute the standard deviation of change from baseline for lung function measures for Altintas 2003, Wang 2009 and Wicher We report effect sizes using values calculated from the larger study Weisgerber 2008 and included those calculated from Weisgerber 2003 in sensitivity analyses in Table 2 and Table 3. Although there were small variations in the effect sizes, the direction of difference did not change for any outcome. D I S C U S S I O N Summary of main results This review set out to determine the effectiveness of swimming training as an intervention for asthma in children and adolescents. There were no studies comparing swimming training with a usual care non-active control group for the primary outcomes, quality of life, asthma exacerbations or use of corticosteroids for asthma. No significant benefit on asthma symptoms was seen in studies comparing swimming training with any control group (Summary of findings for the main comparison). When swimming training was compared with an active control group in one study (Weisgerber 2008), there were no differences in quality of life for children and caregivers, asthma control, exacerbations of asthma and asthmarelated healthcare utilisation. There were statistically significant benefits for swimming training on resting lung function measured at the conclusion of the swimming or control period, for FEV1, FVC and FEF 25% to 75%, expressed as absolute or percentage predicted values. The difference in FEV1 of 100 ml between swimming and control groups is clinically meaningful and comparable to that found in children with asthma treated with inhaled fluticasone propionate 100 mcg (Adams 2008). There were significant benefits for swimming training on cardio-pulmonary fitness compared to a nonactive control measured by maximum oxygen uptake. The 25% difference for swimming compared to control in VO 2 max is clinically meaningful. It exceeds the differences seen in a review of physical activity studies in children without asthma, range 5% to 15% (Armstrong 2011) and the 9% difference seen in children with asthma undertaking physical training (Counil 2003). When pooling VO 2 max with other measures of exercise capacity, the result was of similar magnitude. Overall completeness and applicability of evidence The eight included studies randomised 262 participants who commenced an intervention, while 42 participants withdrew early (Table 4; Table 5). The number of studies on which conclusions are based are relatively few thus limiting available data. Four studies (Altintas 2003; Matsumoto 1999; Varray 1991; Varray 1995) that focused on cardiopulmonary fitness measures reported few withdrawals. Three studies assessed asthma control and lung function (Wang 2009; Weisgerber 2003; Weisgerber 2008) while one study measured lung function and bronchial hyper-responsiveness (Wicher 2010). Outcomes assessing cardiopulmonary fitness, asthma symptoms and lung function were measured at baseline and at the end of the intervention or control period. A recently published update of a review comparing the effects of physical training in participants of all ages with asthma (Chandratilleke 2012) found exercise is well-tolerated and there was no evidence of adverse effects on asthma symptoms. Our review sought to define the benefits, if any, specifically for swimming training. Since the 1970s, it has been suggested from observational studies that swimming training is not detrimental to asthma control (Fitch 1971; Fitch 1976), and benefits on asthma symptoms and control have been seen in pre - post-observational design studies (Huang 1989; Rothe 1990). This review was unable to add to the evidence on potential harmful effects of chlorine on children and adolescents with asthma from swimming training in non-ventilated pools (Bernard 2010) as the chlorination or ventilation status was not known in four studies, thus restricting use of subgroup analysis. The practicality of the programmes used in the studies varied from a realistic two sessions per week to a programme with six sessions a week that would be much harder to emulate and sustain outside a study environment. Quality of the evidence The eight studies included were randomised controlled trials, although limited published information and lack of response to direct request, meant six studies were classified as at unclear risk of selection bias. No studies could be classified as at low risk for detection bias due to non-blinding of outcome assessors. Attrition bias risk was classified as high in three studies, due to high withdrawal rates (Weisgerber 2003; Weisgerber 2008; Wicher 2010). In Weisgerber 2008 there was a high rate of withdrawal after randomisation but prior to commencing training in both groups (24% swimming, 17% golf). During the programme the with- 17

Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma (Review)

Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma (Review) Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma (Review) Welsh EJ, Cates CJ This is a reprint of a Cochrane review, prepared and maintained by The

More information

This is the publisher s version. This version is defined in the NISO recommended practice RP

This is the publisher s version. This version is defined in the NISO recommended practice RP Journal Article Version This is the publisher s version. This version is defined in the NISO recommended practice RP-8-2008 http://www.niso.org/publications/rp/ Suggested Reference Chong, J., Karner, C.,

More information

Exhaled nitric oxide levels to guide treatment for adults with asthma (Review) Petsky, Helen L.; Kew, Kayleigh M.; Turner, Catherine; Chang, Anne

Exhaled nitric oxide levels to guide treatment for adults with asthma (Review) Petsky, Helen L.; Kew, Kayleigh M.; Turner, Catherine; Chang, Anne Charles Darwin University Petsky, Helen L.; Kew, Kayleigh M.; Turner, Catherine; Chang, Anne Published in: Cochrane Database of Systematic Reviews DOI: 10.1002/14651858.CD011440.pub2 Published: 01/09/2016

More information

Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist.

Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:

More information

KewKM,KarnerC,MindusSM,FerraraG. Cochrane Database of Systematic Reviews.

KewKM,KarnerC,MindusSM,FerraraG. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children(review)

More information

Combination inhaled steroid and long-acting beta -agonist in

Combination inhaled steroid and long-acting beta -agonist in Combination inhaled steroid and long-acting beta 2 -agonist in addition to tiotropium versus tiotropium or combination alone for chronic Karner C, Cates CJ This is a reprint of a Cochrane review, prepared

More information

Exhaled nitric oxide levels to guide treatment for children with asthma (Review)

Exhaled nitric oxide levels to guide treatment for children with asthma (Review) Charles Darwin University Petsky, Helen L.; Kew, Kayleigh M.; Chang, Anne Published in: Cochrane Database of Systematic Reviews DOI: 10.1002/14651858.CD011439.pub2 Published: 08/11/2016 Document Version

More information

Anti-IgE for chronic asthma in adults and children (Review)

Anti-IgE for chronic asthma in adults and children (Review) Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2007, Issue 4

More information

Stopping long-acting beta 2 -agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids (Review)

Stopping long-acting beta 2 -agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids (Review) Stopping long-acting beta 2 -agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids (Review) Ahmad S, Kew KM, Normansell R This is a reprint of a Cochrane review, prepared

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first

More information

Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease(review)

Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease(review) Cochrane Database of Systematic Reviews Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease(review) Puhan MA, Gimeno-Santos E, Cates CJ, Troosters T Puhan MA, Gimeno-Santos

More information

Mepolizumab versus placebo for asthma(review)

Mepolizumab versus placebo for asthma(review) Cochrane Database of Systematic Reviews Mepolizumab versus placebo for asthma(review) PowellC,MilanSJ,DwanK,BaxL,WaltersN PowellC,MilanSJ,DwanK,BaxL,WaltersN. Mepolizumab versus placebo for asthma. Cochrane

More information

Inhaled corticosteroids versus long-acting beta 2 -agonists for chronic obstructive pulmonary disease (Review)

Inhaled corticosteroids versus long-acting beta 2 -agonists for chronic obstructive pulmonary disease (Review) Inhaled corticosteroids versus long-acting beta 2 -agonists for chronic obstructive pulmonary disease (Review) Spencer S, Evans DJ, Karner C, Cates CJ This is a reprint of a Cochrane review, prepared and

More information

Early use of inhaled corticosteroids in the emergency department treatment of acute asthma (Review)

Early use of inhaled corticosteroids in the emergency department treatment of acute asthma (Review) Early use of inhaled corticosteroids in the emergency department treatment of acute asthma (Review) Edmonds ML, Milan SJ, Camargo Jr CA, Pollack CV, Rowe BH This is a reprint of a Cochrane review, prepared

More information

KewKM,DahriK.

KewKM,DahriK. Cochrane Database of Systematic Reviews Long-acting muscarinic antagonists(lama) added to combinationlong-actingbeta 2 -agonistsandinhaled corticosteroids(laba/ics) versus LABA/ICS for adults with asthma(review)

More information

Breathing exercises for chronic obstructive pulmonary disease (Protocol)

Breathing exercises for chronic obstructive pulmonary disease (Protocol) Breathing exercises for chronic obstructive pulmonary disease (Protocol) Holland AE, Hill C, McDonald CF This is a reprint of a Cochrane protocol, prepared and maintained by The Cochrane Collaboration

More information

Cates CJ, Lasserson TJ

Cates CJ, Lasserson TJ Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in Cates CJ, Lasserson TJ This is a reprint of a Cochrane review, prepared

More information

School of Dentistry. What is a systematic review?

School of Dentistry. What is a systematic review? School of Dentistry What is a systematic review? Screen Shot 2012-12-12 at 09.38.42 Where do I find the best evidence? The Literature Information overload 2 million articles published a year 20,000 biomedical

More information

Surveillance report Published: 6 April 2016 nice.org.uk. NICE All rights reserved.

Surveillance report Published: 6 April 2016 nice.org.uk. NICE All rights reserved. Surveillance report 2016 Chronic obstructive pulmonary disease in over 16s: diagnosis and management (2010) NICE guideline CG101 Surveillance report Published: 6 April 2016 nice.org.uk NICE 2016. All rights

More information

Type of intervention Treatment. Economic study type Cost-effectiveness analysis.

Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 micro g twice daily and budesonide 800 micro g twice daily in the treatment of adults and adolescents with asthma Lundback

More information

Anticholinergic therapy for acute asthma in children(review)

Anticholinergic therapy for acute asthma in children(review) Cochrane Database of Systematic Reviews Anticholinergic therapy for acute asthma in children(review) TeohL,CatesCJ,HurwitzM,AcworthJP,vanAsperenP,ChangAB TeohL,CatesCJ,HurwitzM,AcworthJP,vanAsperenP,ChangAB.

More information

Cochrane Breast Cancer Group

Cochrane Breast Cancer Group Cochrane Breast Cancer Group Version and date: V3.2, September 2013 Intervention Cochrane Protocol checklist for authors This checklist is designed to help you (the authors) complete your Cochrane Protocol.

More information

Breathing exercises for children with asthma(review)

Breathing exercises for children with asthma(review) Cochrane Database of Systematic Reviews Breathing exercises for children with asthma(review) Macêdo TMF, Freitas DA, Chaves GSS, Holloway EA, Mendonça KMPP Macêdo TMF, Freitas DA, Chaves GSS, Holloway

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews Drug-eluting balloon angioplasty versus non-stenting balloon angioplasty for peripheral arterial disease of the lower limbs [Cochrane Protocol]

More information

Problem solving therapy

Problem solving therapy Introduction People with severe mental illnesses such as schizophrenia may show impairments in problem-solving ability. Remediation interventions such as problem solving skills training can help people

More information

Surgery versus non-surgical treatment for bronchiectasis (Review)

Surgery versus non-surgical treatment for bronchiectasis (Review) Surgery versus non-surgical treatment for bronchiectasis (Review) Warburton CJ, Corless JA This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in

More information

Cochrane Pregnancy and Childbirth Group Methodological Guidelines

Cochrane Pregnancy and Childbirth Group Methodological Guidelines Cochrane Pregnancy and Childbirth Group Methodological Guidelines [Prepared by Simon Gates: July 2009, updated July 2012] These guidelines are intended to aid quality and consistency across the reviews

More information

Self-management education for patients with chronic obstructive pulmonary disease (Review)

Self-management education for patients with chronic obstructive pulmonary disease (Review) Self-management education for patients with chronic obstructive pulmonary disease (Review) Effing T, Monninkhof EEM, van der Valk PP, Zielhuis GGA, Walters EH, van der Palen JJ, Zwerink M This is a reprint

More information

Respiratory muscle training for cervical spinal cord injury (Review)

Respiratory muscle training for cervical spinal cord injury (Review) Respiratory muscle training for cervical spinal cord injury (Review) Berlowitz D, Tamplin J This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in

More information

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Antifibrinolytic drugs for acute traumatic injury(review)

Antifibrinolytic drugs for acute traumatic injury(review) Cochrane Database of Systematic Reviews Antifibrinolytic drugs for acute traumatic injury(review) KerK,RobertsI,ShakurH,CoatsTJ KerK,RobertsI,ShakurH,CoatsTJ. Antifibrinolytic drugs for acute traumatic

More information

SYNOPSIS. Study center(s) This study was conducted in the United States (128 centers).

SYNOPSIS. Study center(s) This study was conducted in the United States (128 centers). Drug product: Drug substance(s): Document No.: Edition No.: Study code: Date: SYMBICORT pmdi 160/4.5 µg Budesonide/formoterol SD-039-0725 17 February 2005 SYNOPSIS A Twelve-Week, Randomized, Double-blind,

More information

Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department (Review)

Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department (Review) Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department (Review) Kew KM, Kirtchuk L, Michell CI This is a reprint of a Cochrane review, prepared and maintained by

More information

Standards for the reporting of new Cochrane Intervention Reviews

Standards for the reporting of new Cochrane Intervention Reviews Methodological Expectations of Cochrane Intervention Reviews (MECIR) Standards for the reporting of new Cochrane Intervention Reviews 24 September 2012 Preface The standards below summarize proposed attributes

More information

Inhaled corticosteroids versus long-acting beta 2 -agonists for chronic obstructive pulmonary disease (Review)

Inhaled corticosteroids versus long-acting beta 2 -agonists for chronic obstructive pulmonary disease (Review) Inhaled corticosteroids versus long-acting beta 2 -agonists for chronic obstructive pulmonary disease (Review) Spencer S, Karner C, Cates CJ, Evans DJ This is a reprint of a Cochrane review, prepared and

More information

Addition to inhaled corticosteroids of long-acting beta2- agonists versus anti-leukotrienes for chronic asthma (Review)

Addition to inhaled corticosteroids of long-acting beta2- agonists versus anti-leukotrienes for chronic asthma (Review) Addition to inhaled corticosteroids of long-acting beta2- agonists versus anti-leukotrienes for chronic asthma (Review) Ducharme FM, Lasserson TJ, Cates CJ This is a reprint of a Cochrane review, prepared

More information

University of Groningen

University of Groningen University of Groningen Bronchodilators delivered by nebuliser versus pmdi with spacer or DPI for exacerbations of COPD van Geffen, Wouter H.; Douma, W. R.; Slebos, Dirk Jan; Kerstjens, Huib A. M. Published

More information

(Asthma) Diagnosis, monitoring and chronic asthma management

(Asthma) Diagnosis, monitoring and chronic asthma management Dubai Standards of Care 2018 (Asthma) Diagnosis, monitoring and chronic asthma management Preface Asthma is one of the most common problem dealt with in daily practice. In Dubai, the management of chronic

More information

Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library)

Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library) A systematic review of smoking cessation and relapse prevention interventions in parents of babies admitted to a neonatal unit (after delivery) Divya Nelson, Sarah Gentry, Caitlin Notley, Henry White,

More information

Animal-assisted therapy

Animal-assisted therapy Introduction Animal-assisted interventions use trained animals to help improve physical, mental and social functions in people with schizophrenia. It is a goal-directed intervention in which an animal

More information

Results. NeuRA Hypnosis June 2016

Results. NeuRA Hypnosis June 2016 Introduction may be experienced as an altered state of consciousness or as a state of relaxation. There is no agreed framework for administering hypnosis, but the procedure often involves induction (such

More information

Data extraction. Specific interventions included in the review Dressings and topical agents in relation to wound healing.

Data extraction. Specific interventions included in the review Dressings and topical agents in relation to wound healing. Systematic reviews of wound care management: (2) dressings and topical agents used in the healing of chronic wounds Bradley M, Cullum N, Nelson E A, Petticrew M, Sheldon T, Torgerson D Authors' objectives

More information

Nebulised hypertonic saline for cystic fibrosis.

Nebulised hypertonic saline for cystic fibrosis. Revista: Cochrane Database Syst Rev. 2003;(1):CD001506. Nebulised hypertonic saline for cystic fibrosis. Autor: Wark PA, McDonald V. Source: Department of Respiratory Medicine, John Hunter Hospital, Locked

More information

Ivax Pharmaceuticals UK Sponsor Submission to the National Institute for Health and Clinical Excellence

Ivax Pharmaceuticals UK Sponsor Submission to the National Institute for Health and Clinical Excellence Ivax Pharmaceuticals UK Sponsor Submission to the National Institute for Health and Clinical Excellence Clinical and cost-effectiveness of QVAR for the treatment of chronic asthma in adults and children

More information

SYNOPSIS. Date 15 June 2004

SYNOPSIS. Date 15 June 2004 Drug product Drug substance(s) Document No. Edition No. Study code SYMBICORT pmdi 160/4.5 mg per actuation Budesonide/formoterol SD-039-0719 Date 15 June 2004 SYNOPSIS A Six-Month, Randomized, Open-Label

More information

T A B L E O F C O N T E N T S

T A B L E O F C O N T E N T S Short-term psychodynamic psychotherapies for anxiety, depression and somatoform disorders (Unknown) Abbass AA, Hancock JT, Henderson J, Kisely S This is a reprint of a Cochrane unknown, prepared and maintained

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews Effectiveness of collaborative care in patients with combined physical disorders and depression or anxiety disorder: a systematic review

More information

Self management for patients with chronic obstructive pulmonary disease(review)

Self management for patients with chronic obstructive pulmonary disease(review) Cochrane Database of Systematic Reviews Self management for patients with chronic obstructive pulmonary disease(review) Zwerink M, Brusse-Keizer M, van der Valk PDLPM, Zielhuis GA, Monninkhof EM, van der

More information

Omalizumab for asthma in adults and children(review)

Omalizumab for asthma in adults and children(review) Cochrane Database of Systematic Reviews Omalizumab for asthma in adults and children(review) NormansellR,WalkerS,MilanSJ,WaltersEH,NairP NormansellR,WalkerS,MilanSJ,WaltersEH,NairP. Omalizumab for asthma

More information

DR REBECCA THOMAS CONSULTANT RESPIRATORY PHYSICIAN YORK DISTRICT HOSPITAL

DR REBECCA THOMAS CONSULTANT RESPIRATORY PHYSICIAN YORK DISTRICT HOSPITAL DR REBECCA THOMAS CONSULTANT RESPIRATORY PHYSICIAN YORK DISTRICT HOSPITAL Definition Guidelines contact complicated definitions Central to this is Presence of symptoms Variable airflow obstruction Diagnosis

More information

Inhaled corticosteroids for subacute and chronic cough in adults (Review)

Inhaled corticosteroids for subacute and chronic cough in adults (Review) Inhaled corticosteroids for subacute and chronic cough in adults (Review) Johnstone KJ, Chang AB, Fong KM, Bowman RV, Yang IA This is a reprint of a Cochrane review, prepared and maintained by The Cochrane

More information

Asthma: diagnosis and monitoring

Asthma: diagnosis and monitoring Asthma: diagnosis and monitoring NICE guideline: short version Draft for second consultation, July 01 This guideline covers assessing, diagnosing and monitoring suspected or confirmed asthma in adults,

More information

Asthma Pharmacotherapy Adherence Interventions for Adult African-Americans: A Systematic Review. Isaretta L. Riley, MD

Asthma Pharmacotherapy Adherence Interventions for Adult African-Americans: A Systematic Review. Isaretta L. Riley, MD Asthma Pharmacotherapy Adherence Interventions for Adult African-Americans: A Systematic Review By Isaretta L. Riley, MD A Master s Paper submitted to the faculty of the University of North Carolina at

More information

Asthma: Chronic Management. Yung-Yang Liu, MD Attending physician, Chest Department Taipei Veterans General Hospital April 26, 2015

Asthma: Chronic Management. Yung-Yang Liu, MD Attending physician, Chest Department Taipei Veterans General Hospital April 26, 2015 Asthma: Chronic Management Yung-Yang Liu, MD Attending physician, Chest Department Taipei Veterans General Hospital April 26, 2015 Global Strategy for Asthma Management and Prevention Evidence-based Implementation

More information

Kew KM, Evans DJW, Allison DE, Boyter AC

Kew KM, Evans DJW, Allison DE, Boyter AC Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta 2 - agonists (LABA) Kew KM, Evans DJW, Allison DE, Boyter AC This is a reprint of a

More information

Diagnosis and Management of Asthma in Children based on the British Thoracic Society and Scottish Intercollegiate Guidelines Network September 2016

Diagnosis and Management of Asthma in Children based on the British Thoracic Society and Scottish Intercollegiate Guidelines Network September 2016 Diagnosis and Management of Asthma in Children based on the British Thoracic Society and Scottish Intercollegiate Guidelines Network September 2016 Diagnosis: There is no lower limit to the age at which

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews Closed reduction methods for acute anterior shoulder dislocation [Cochrane Protocol] Kanthan Theivendran, Raj Thakrar, Subodh Deshmukh,

More information

Is there any evidence that multi disciplinary pulmonary rehabilitation impacts on quality of life?

Is there any evidence that multi disciplinary pulmonary rehabilitation impacts on quality of life? Is there any evidence that multi disciplinary pulmonary rehabilitation impacts on quality of life? Summary of the evidence located: According to the NICE guideline on Chronic Obstructive Pulmonary Disease

More information

NICE guideline Published: 29 November 2017 nice.org.uk/guidance/ng80

NICE guideline Published: 29 November 2017 nice.org.uk/guidance/ng80 Asthma: diagnosis, monitoring and chronic asthma management NICE guideline Published: 29 November 2017 nice.org.uk/guidance/ng80 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma

Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma Magnitude of Asthma - India Delhi Childhood asthma: 10.9% Adults: 8% Other Cities 3 to 18% Chhabra SK et al Ann Allergy Asthma

More information

Background: Traditional rehabilitation after total joint replacement aims to improve the muscle strength of lower limbs,

Background: Traditional rehabilitation after total joint replacement aims to improve the muscle strength of lower limbs, REVIEWING THE EFFECTIVENESS OF BALANCE TRAINING BEFORE AND AFTER TOTAL KNEE AND TOTAL HIP REPLACEMENT: PROTOCOL FOR A SYSTEMATIC RE- VIEW AND META-ANALYSIS Background: Traditional rehabilitation after

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews Prophylactic cranial irradiation in patients with non-small-cell lung cancer: a systematic review and meta-analysis of randomized controlled

More information

April 10 th, Bond Street, Toronto ON, M5B 1W8

April 10 th, Bond Street, Toronto ON, M5B 1W8 Comprehensive Research Plan: Inhaled long-acting muscarinic antagonists (LAMAs; long-acting anticholinergics) for the treatment of chronic obstructive pulmonary disease (COPD) April 10 th, 2014 30 Bond

More information

Results. NeuRA Herbal medicines August 2016

Results. NeuRA Herbal medicines August 2016 Introduction have been suggested as a potential alternative treatment which may positively contribute to the treatment of schizophrenia. Herbal therapies can include traditional Chinese medicines and Indian

More information

Results. NeuRA Treatments for dual diagnosis August 2016

Results. NeuRA Treatments for dual diagnosis August 2016 Introduction Many treatments have been targeted to improving symptom severity for people suffering schizophrenia in combination with substance use problems. Studies of dual diagnosis often investigate

More information

5-ASA for the treatment of Crohn s disease DR. STEPHEN HANAUER FEINBERG SCHOOL OF MEDICINE, NORTHWESTERN UNIVERSITY, CHICAGO, IL, USA

5-ASA for the treatment of Crohn s disease DR. STEPHEN HANAUER FEINBERG SCHOOL OF MEDICINE, NORTHWESTERN UNIVERSITY, CHICAGO, IL, USA 5-ASA for the treatment of Crohn s disease DR. STEPHEN HANAUER FEINBERG SCHOOL OF MEDICINE, NORTHWESTERN UNIVERSITY, CHICAGO, IL, USA Background RCTs investigating the efficacy of aminosalicylates for

More information

Allergen immunotherapy for the treatment of allergic rhinitis and/or asthma

Allergen immunotherapy for the treatment of allergic rhinitis and/or asthma ril 2014 Allergen immunotherapy for the treatment of allergic rhinitis and/or asthma FINAL COMPREHENSIVE RESEARCH PLAN June 2015 Study Team: Systematic Review Unit FINAL COMPREHENSIVE RESEARCH PLAN: Systematic

More information

Web appendix: Supplementary data

Web appendix: Supplementary data Web appendix: Supplementary data Azad MA, Coneys JG, Kozyrskyj AL, Field CJ, Ramsey CD, Becker AB, Friesen C, Abou-Setta AM, Zarychanski R. Probiotic supplementation during pregnancy or infancy for the

More information

Research activity following Asthma Treatment Uncertainty Priority Setting Exercise in 2007 paper updated January 2010

Research activity following Asthma Treatment Uncertainty Priority Setting Exercise in 2007 paper updated January 2010 Research activity following Asthma Treatment Uncertainty Priority Setting Exercise in 2007 paper updated January 2010 This paper captures relevant research activity following the completion of JLA priority

More information

Joint Session ACOFP and AOASM: Exercise Induced Asthma. Bruce Dubin, DO, JD, FCLM, FACOI

Joint Session ACOFP and AOASM: Exercise Induced Asthma. Bruce Dubin, DO, JD, FCLM, FACOI Joint Session ACOFP and AOASM: Exercise Induced Asthma Bruce Dubin, DO, JD, FCLM, FACOI ACOFP FULL DISCLOSURE FOR CME ACTIVITIES Please check where applicable and sign below. Provide additional pages as

More information

Results. NeuRA Motor dysfunction April 2016

Results. NeuRA Motor dysfunction April 2016 Introduction Subtle deviations in various developmental trajectories during childhood and adolescence may foreshadow the later development of schizophrenia. Studies exploring these deviations (antecedents)

More information

Is reslizumab effective in improving quality of life and asthma control in adolescent and adult patients with poorly controlled eosinophilic asthma?

Is reslizumab effective in improving quality of life and asthma control in adolescent and adult patients with poorly controlled eosinophilic asthma? Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2018 Is reslizumab effective in improving

More information

Time-lapse systems for embryo incubation and assessment in assisted reproduction(review)

Time-lapse systems for embryo incubation and assessment in assisted reproduction(review) Cochrane Database of Systematic Reviews Time-lapse systems for embryo incubation and assessment in assisted reproduction(review) ArmstrongS,ArrollN,CreeLM,JordanV,FarquharC ArmstrongS,ArrollN,CreeLM,JordanV,FarquharC.

More information

Determinants of quality: Factors that lower or increase the quality of evidence

Determinants of quality: Factors that lower or increase the quality of evidence Determinants of quality: Factors that lower or increase the quality of evidence GRADE Workshop CBO, NHG and Dutch Cochrane Centre CBO, April 17th, 2013 Outline The GRADE approach: step by step Factors

More information

Downloaded from:

Downloaded from: Arnup, SJ; Forbes, AB; Kahan, BC; Morgan, KE; McKenzie, JE (2016) The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality. Trials,

More information

Traumatic brain injury

Traumatic brain injury Introduction It is well established that traumatic brain injury increases the risk for a wide range of neuropsychiatric disturbances, however there is little consensus on whether it is a risk factor for

More information

ASTRAZENECA v GLAXOSMITHKLINE

ASTRAZENECA v GLAXOSMITHKLINE CASE AUTH/1833/5/06 ASTRAZENECA v GLAXOSMITHKLINE CONCEPT study leavepiece AstraZeneca complained that a leavepiece issued by Allen & Hanburys, part of GlaxoSmithKline, did not present a fair and balanced

More information

Predicting, Preventing and Managing Asthma Exacerbations. Heather Zar Department of Paediatrics & Child Health University of Cape Town South Africa

Predicting, Preventing and Managing Asthma Exacerbations. Heather Zar Department of Paediatrics & Child Health University of Cape Town South Africa Predicting, Preventing and Managing Asthma Exacerbations Heather Zar Department of Paediatrics & Child Health University of Cape Town South Africa Asthma exacerbations Predicting exacerbation recognising

More information

Patient characteristics Intervention Comparison Length of followup

Patient characteristics Intervention Comparison Length of followup ORAL MUCOLYTICS Ref ID: 2511 Bachh AA, Shah NN, Bhargava R et al. Effect oral N- in COPD - A randomised controlled trial. JK Practitioner. 2007; 14(1):12-16. Ref ID: 2511 RCT Single blind; unclear allocation

More information

Allwin Mercer Dr Andrew Zurek

Allwin Mercer Dr Andrew Zurek Allwin Mercer Dr Andrew Zurek 1 in 11 people are currently receiving treatment for asthma (5.4 million people in the UK) Every 10 seconds, someone is having a potentially life-threatening asthma attack

More information

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Co-Primary Outcomes/Efficacy Variables:

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Co-Primary Outcomes/Efficacy Variables: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Results. NeuRA Treatments for internalised stigma December 2017

Results. NeuRA Treatments for internalised stigma December 2017 Introduction Internalised stigma occurs within an individual, such that a person s attitude may reinforce a negative self-perception of mental disorders, resulting in reduced sense of selfworth, anticipation

More information

Secondary Outcome/Efficacy Variable(s):

Secondary Outcome/Efficacy Variable(s): The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Self-management education for cystic fibrosis

Self-management education for cystic fibrosis Title Author(s) Savage, Eileen; Beirne, Paul V.; Ní Chróinín, Muireann; Duff, Alistair; Fitzgerald, Anthony P.; Farrell, Dawn Publication date 2014-09 Original citation Savage E, Beirne PV, Ni Chroinin

More information

RESPIRATORY CARE IN GENERAL PRACTICE

RESPIRATORY CARE IN GENERAL PRACTICE RESPIRATORY CARE IN GENERAL PRACTICE Definitions of Asthma and COPD Asthma is due to inflammation of the air passages in the lungs and affects the sensitivity of the nerve endings in the airways so they

More information

Therapeutic ultrasound for carpal tunnel syndrome (Review)

Therapeutic ultrasound for carpal tunnel syndrome (Review) Page MJ, O Connor D, Pitt V, Massy-Westropp N This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2012, Issue 1 http://www.thecochranelibrary.com

More information

Lead team presentation: Roflumilast for treating chronic obstructive pulmonary disease [ID984]

Lead team presentation: Roflumilast for treating chronic obstructive pulmonary disease [ID984] Lead team presentation: Roflumilast for treating chronic obstructive pulmonary disease [ID984] 1 st Appraisal Committee meeting Background & Clinical Effectiveness John McMurray 11 th January 2016 For

More information

GINA. At-A-Glance Asthma Management Reference. for adults, adolescents and children 6 11 years. Updated 2017

GINA. At-A-Glance Asthma Management Reference. for adults, adolescents and children 6 11 years. Updated 2017 GINA At-A-Glance Asthma Management Reference for adults, adolescents and children 6 11 years Updated 2017 This resource should be used in conjunction with the Global Strategy for Asthma Management and

More information

ADULT ASTHMA GUIDE SUMMARY. This summary provides busy health professionals with key guidance for assessing and treating adult asthma.

ADULT ASTHMA GUIDE SUMMARY. This summary provides busy health professionals with key guidance for assessing and treating adult asthma. ADULT ASTHMA GUIDE SUMMARY This summary provides busy health professionals with key guidance for assessing and treating adult asthma. Its source document Asthma and Respiratory Foundation NZ Adult Asthma

More information

On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children

On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children 7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists

More information

Nonsteroidal anti-inflammatory drugs and perioperative bleeding in paediatric tonsillectomy (Review)

Nonsteroidal anti-inflammatory drugs and perioperative bleeding in paediatric tonsillectomy (Review) Nonsteroidal anti-inflammatory drugs and perioperative bleeding in paediatric tonsillectomy (Review) Lewis SR, Nicholson A, Cardwell ME, Siviter G, Smith AF This is a reprint of a Cochrane review, prepared

More information

The Office of Evidence Based Practice, 2011 Center of Clinical Effectiveness. Importance. Quality. No of studies

The Office of Evidence Based Practice, 2011 Center of Clinical Effectiveness. Importance. Quality. No of studies Question 6: In the child with asthma exacerbation in the ED should magnesium sulfate IV be used prevent hospitalization, decrease time in the ED, and improve pulmonary function? GRADEprofiler Table: Rowe

More information

Tips on managing asthma in children

Tips on managing asthma in children Tips on managing asthma in children Dr Ranjan Suri Consultant in Respiratory Paediatrics Bupa Cromwell Hospital Clinics: Friday (pm) Asthma in Children Making the diagnosis Patterns of childhood asthma

More information

Supplementary Medications during asthma attack. Prof. Dr Finn Rasmussen PhD. DrMedSc. Near East University Hospital North Cyprus

Supplementary Medications during asthma attack. Prof. Dr Finn Rasmussen PhD. DrMedSc. Near East University Hospital North Cyprus Supplementary Medications during asthma attack Prof. Dr Finn Rasmussen PhD. DrMedSc. Near East University Hospital North Cyprus Conflicts of Interest None Definition of Asthma Airway narrowing that is

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: bronchial_thermoplasty 10/2010 3/2018 3/2019 3/2018 Description of Procedure or Service Bronchial thermoplasty

More information

Presented by the California Academy of Family Physicians 2013/California Academy of Family Physicians

Presented by the California Academy of Family Physicians 2013/California Academy of Family Physicians Family Medicine and Patient-Centered Asthma Care Presented by the California Academy of Family Physicians Faculty: Hobart Lee, MD Disclosures: Jeffrey Luther, MD, Program Director, Memorial Family Medicine

More information

NB: This chapter is a concise version of the full Cochrane review

NB: This chapter is a concise version of the full Cochrane review CHAPTER 5 Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults Nikki Claassen- van Dessel Madelon den Boeft Johannes C van der Wouden

More information

Standards for the conduct and reporting of new Cochrane Intervention Reviews 2012

Standards for the conduct and reporting of new Cochrane Intervention Reviews 2012 Methodological Expectations of Cochrane Intervention Reviews (MECIR) s for the conduct and reporting of new Cochrane Intervention Reviews 2012 Booklet Version 2 September 2013 1 Preface Cochrane Reviews

More information

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information